Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases CAIRO5 a Randomized Phase 3 Study of the Dutch Colorectal Cancer Group (DCCG)
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Bevacizumab (Primary) ; Panitumumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CAIRO5
- 12 Oct 2017 Planned number of patients changed from 640 to 564.
- 05 Oct 2016 According to Amgen media release, data from this trial will be presented at the European Society for Medical Oncology (ESMO) 2016 Congress.
- 11 Feb 2016 New trial record